Current controversies in bone densitometry

Current Opinion in Rheumatology

Volumn 14, Issue 4, 2002, Pages 416-420

  Bonnick, Sydney Lou ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PARATHYROID HORMONE; RALOXIFENE; RISEDRONIC ACID; SALCATONIN; BIOLOGICAL MARKER;

BONE DENSITY; CLINICAL PRACTICE; DENSITOMETRY; FEMALE; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION; BONE; ECHOGRAPHY; METABOLISM; RADIODENSITOMETRY; RADIOGRAPHY; REFERENCE VALUE; REPRODUCIBILITY;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HUMAN; OSTEOPOROSIS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY; HUMANS;

EID: 0035985855     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200207000-00015     Document Type: Review

References (35)

1. Prophylaxis and treatment of osteoporosis
2. Diagnosis, prophylaxis, and treatment of osteoporosis
3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
4. Discrepancies in normative data between Lunar and Hologic DXA systems
5. Proximal femur bone mineral levels of US adults
6. Classification of osteoporosis in the elderly is dependent on site-specific analysis
7. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The OFELY cohort
8. Dissimilar spine and femoral z-scores in premenopausal women
9. Reproducibility of DXA: Potential impact on serial measurements and misclassification of osteoporosis
10. Discordance in patient classification using T-scores
11. An update on the diagnosis and assessment of osteoporosis with densitometry
12. Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis
13. A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women
14. Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause
15. Imaging ultrasonometry of the calcaneus: Optimum T-score thresholds for the identification of osteoporotic subjects
16. Classification of osteoporosis based on bone mineral densities
17. A proposal to establish comparable diagnostic categories for bone densitometry based on hip fracture risk among Caucasian women over age 65
18. Peripheral or central densitometry: Does it matter which technique we use?
19. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracture
20. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women
21. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
22. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
23. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
24. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study
25. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
26. Predicting the effect of antiresorptive treatments on risk of vertebral fractures: A meta-analysis
27. What proportion of the effects of raloxifene (RLX) on vertebral fracture risk can be directly attributed to its bone mineral density (BMD) effects?
28. How much of the reduction in risk of vertebral fractures by alendronate is explained by increased spine BMD?
29. Antifracture efficacy of antiresorptive agents are related to changes in bone density
30. Bone matters: Are density increases necessary to reduce fracture risk?
31. Monitoring osteoporosis therapy with bone densitometry: Misleading changes and regression to the mean
32. Monitoring osteoporosis therapy with bone densitometry: A vital tool or regression toward mediocrity?
33. Realities and probabilities
34. The importance of precision in bone density measurements
35. Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniques